| |
| |
|
| Insider
Information: |
Shackelford Jason T |
| Relationship: |
Prin Fin. & Acct. Offi... |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
19,453 |
|
|
Indirect Shares
|
95 |
|
|
| Direct
Value |
$6,665 |
|
|
|
Indirect Value
|
$33 |
|
|
| Total
Shares |
19,548 |
|
|
| Total
Value |
$6,697 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
Prin Fin. & Acct. Offi... |
2018-06-20 |
19,453 |
2018-06-20 |
95 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Prin Fin. & Acct. Officer |
• – – |
2018-06-20 |
4 |
S |
$19.01 |
$176,350 |
D/D |
(9,279) |
19,453 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Prin Fin. & Acct. Officer |
• – – |
2018-01-05 |
4 |
S |
$11.13 |
$35,024 |
D/D |
(3,090) |
28,732 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Prin Fin. & Acct. Officer |
• – – |
2018-01-01 |
4 |
D |
$12.71 |
$34,368 |
D/D |
(2,704) |
31,822 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Prin Fin. & Acct. Officer |
• – – |
2015-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
345,263 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Prin Fin. & Acct. Officer |
• – – |
2014-08-07 |
4 |
B |
$0.92 |
$9,172 |
D/D |
10,000 |
45,263 |
2.74 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Prin Fin. & Acct. Officer |
• – – |
2014-06-01 |
4 |
D |
$1.66 |
$24,463 |
D/D |
(14,737) |
35,263 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Principal Accounting OfficerOf |
• – – |
2013-12-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Principal Accounting OfficerOf |
• – – |
2013-12-20 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
50,600 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Principal Accounting OfficerOf |
• – – |
2013-12-20 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
350 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
